Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 09, 2022 07:23 ET | Source: Lupin Ltd

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla® Agreement enables expanded patient access of the only EU-approved treatment for myotonia symptoms in non-dystrophic myotonic...